ACP
Altitude Crest Partners Portfolio holdings
AUM
$234M
This Quarter Return
+28.31%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$234M
AUM Growth
+$234M
(+56%)
Cap. Flow
+$90.1M
Cap. Flow
% of AUM
38.56%
Top 10 Holdings %
Top 10 Hldgs %
69.27%
Holding
34
New
22
Increased
2
Reduced
4
Closed
4
Top Buys
| 1 |
Stevanato
STVN
|
$17.7M |
| 2 |
Thermo Fisher Scientific
TMO
|
$10.7M |
| 3 |
ArriVent BioPharma
AVBP
|
$9.92M |
| 4 |
Structure Therapeutics
GPCR
|
$8.79M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$7.94M |
Top Sells
| 1 |
argenx
ARGX
|
$11.2M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$11M |
| 3 |
Exact Sciences
EXAS
|
$7.33M |
| 4 |
BridgeBio Pharma
BBIO
|
$4.41M |
| 5 |
Roivant Sciences
ROIV
|
$3.72M |
Sector Composition
| 1 | Healthcare | 99.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Zymeworks
ZYME
$1.12B
| $1.53M | 0.66% |
+145,581
| New | +$1.53M |
|
27
Metagenomi
MGX
$68.3M
| $1.41M | 0.6% |
+133,333
| New | +$1.41M |
|
28
Tourmaline Bio
TRML
$601M
| $1.09M | 0.46% |
+47,400
| New | +$1.09M |
|
29
Alnylam Pharmaceuticals
ALNY
$58.5B
| $29.9K | 0.01% |
+200
| New | +$29.9K |
|
30
Surrozen, Inc. Warrant
SRZNW
$71.9K
| $12.5K | 0.01% |
384,573
| – | – |
|
|
31
argenx
ARGX
$43.6B
| – | – |
-29,500
| Closed | -$11.2M |
|
|
32
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – |
-114,042
| Closed | -$11M |
|
|
33
Exact Sciences
EXAS
$9.09B
| – | – |
-99,130
| Closed | -$7.33M |
|
|
AMAM
34
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| – | – |
-43,100
| Closed | -$614K |
|